Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. leiter's cambrian park drugs, inc.,
483
•leiter's cambrian park drugs, inc., •November 5, 2013

leiter's cambrian park drugs, inc., – FDA 483, Nov 5, 2013

Record Details

During an inspection from October 22 to November 5, 2013, the FDA identified significant manufacturing deficiencies at Leiter's Cambrian Park Drugs, Inc., operating as Leiter's Pharmacy, a producer of sterile drugs in San Jose, CA. The inspection, documented in an FDA Form 483, revealed widespread non-compliance with current Good Manufacturing Practices (cGMP) for sterile drug production. Key violations included a severe lack of validation for sterilization processes, with missing media fill incubation records and unvalidated equipment. The firm also failed to thoroughly investigate a positive sterility test result for a Bevacizumab injection batch, which showed microbial contamination, without a documented root cause analysis. Aseptic processing areas were compromised by inadequate environmental monitoring, a lack of airflow evaluations, and insufficient cleaning and disinfection procedures. Protective apparel protocols were also found deficient, with personnel exhibiting improper gowning and hygiene practices that risked product contamination. Furthermore, quality control procedures were inadequate, with records not being reviewed, critical gauges uncalibrated, and a lack of written procedures for cleaning agents and shipping validation. The facility's space was deemed insufficient, contributing to contamination risks and operational constraints. Leiter's Pharmacy is required to promptly address these systemic failures to ensure the safety, identity, strength, quality, and purity of its sterile drug products, providing a comprehensive response outlining corrective and preventive actions to the FDA.

Company
leiter's cambrian park drugs, inc.,
Inspection date
November 5, 2013
Product type
Drugs
Office
San Francisco District Office
People
  • Jennifer H. Rhyu
  • Thomas J. Arista
View Company Profile

ID · 7484c72f-aa13-4fd6-a14e-2ac5dc353ab8

Violation Codes1
21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for leiter's cambrian park drugs, inc.,
  • 483 - 2014-03-06March 6, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore leiter's cambrian park drugs, inc.,
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.